AzTrials
AzTrials

Aneurysm AorticNCT05247944

F-BEVAR vs Open Surgery for Complex Abdominal Aortic Aneurysm

An observational study of Aneurysm Aortic and Vascular Diseases, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study was to investigate outcomes of a propensity matched series of patients treated with F-BEVAR and open surgery repair for complex abdominal aortic aneurysm in two aortic high-volume centres. Read more about this study

Who is it for?
Any age
Conditions the study is for
Aneurysm Aortic, Vascular Diseases
What is being tested?
Fenestrated and branched endovascular aortic repair (F-BEVAR) and Open repair
Type of treatment
Surgery or procedure
How many people
278 participants
Where
No sites listed yet
Study dates
Jan 2010to Jan 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: A total of 157 patients, referred to the Aortic Center of Lille (France), underwent F-BEVAR treatment; 119 patients, referred to the Policlinic Gemelli in Rome (Italy), concurrently underwent OSR.

Who may be able to join

  • juxtarenal abdominal aortic aneurysms
  • pararenal abdominal aortic aneurysms
  • suprarenal abdominal aortic aneurysms
  • type IV thoracoabdominal aneurysms

Who cannot join

  • extent I to III thoracoabdominal aneurysms
  • ruptured o symptomatic aneurysms
  • dissections or connective tissue disorder aneurysms.

About this study

Official title: Propensity Matched Comparison of Fenestrated Endovascular Aneurysm Repair and Open Surgical Repair for Complex Abdominal Aortic Aneurysms.

The aim of the present study was to investigate outcomes of a propensity matched series of patients treated with F-BEVAR and open surgery repair for complex abdominal aortic aneurysm in two aortic high-volume centres.

Read the detailed description

This retrospective study analyzes the long-term outcomes of a propensity-matched cohort of patients with complex abdominal aortic aneurysm prospectively collected between January 2010 and June 2016 from the Aortic Center of Lille (Lille, France) and the Unit of Vascular Surgery of Policlinic Gemelli (Rome, Italy).

Patients were observed with regular postoperative appointments. The long-term imaging follow-up consisted in a yearly computed tomography angiography in the F-BEVAR group; and yearly abdominal ultrasound examination and 5-year computed tomography angiography were performed in the open surgery repair group. In case of abnormal renal function (eGFR<60 mL/min/1.73 m2), the patient underwent computed tomography without contrast associated to a contrast-enhanced ultrasound examination in both groups. Laboratory data with evaluation of renal function by estimated glomerular filtration rate (eGFR), were completed at three, six, and 12 months, and yearly thereafter. Survival assessment was completed after general partitioner's, patients' or patient siblings' contact by phone.

Being tested
Fenestrated and branched endovascular aortic repair (F-BEVAR), Open repair
Keywords
F-BEVAR, Open surgery, complex abdominal aortic aneurysm
Medical subject headings
Aortic Aneurysm, Vascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fenestrated and branched endovascular aortic repair (F-BEVAR)Procedure or surgery

    Fenestrated and branched endovascular aortic repair (F-BEVAR)

  • Open repairProcedure or surgery

    Open surgery for complex abdominal aortic aneurysm

Study groups in NCT05247944
Study groupRoleWhat they receive
F-BEVARPatients with complex abdominal aortic aneurysm who underwent fenestrated and branched endovascular aortic repair (F-BEVAR) at the Aortic Center of Lille (ACL; Lille, France).
Receives: Procedure: Fenestrated and branched endovascular aortic repair (F-BEVAR)
OPEN SURGERY REPAIRPatients with complex abdominal aortic aneurysm who underwent open surgery repair the Unit of Vascular Surgery of Policlinic Gemelli (FPUG; Rome, Italy).
Receives: Procedure: Open repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall mortality

    All cause death

    Measured: Through study completion, an average of 5 year

  2. Aortic-related mortality

    Any death related to the initial procedure.

    Measured: Through study completion, an average of 5 year

  3. Chronic renal decline during follow-up

    Chronic renal decline was defined in patients with normal (stage 1-2) preoperative renal function as a reduction in the eGFR to <60 mL/min/1.73 m2 during follow-up. In patients with abnormal function (stages 3 and 4) preoperatively, it was defined as an eGFR reduction of >20% or de novo dependence on permanent renal replacement therapy.

    Measured: Through study completion, an average of 5 year

Secondary outcomes (4)
  1. Aortic-related reintervention

    All secondary interventions related to the initial procedure or to the endograft and its target vessels during follow-up

    Measured: Through study completion, an average of 5 year

  2. Target vessel occlusion

    Complete obstruction of the artery with no evidence of flow identified on any follow-up CT scan or duplex ultrasound.

    Measured: Through study completion, an average of 5 year

  3. Clinical failure

    Death from complications of the initial operation or a secondary intervention, aortic aneurysm rupture, aortic conversion to open surgical repair, persistent type I or III endoleak, sac expansion >5 mm, device migration >10mm, infection or thrombosis in the F-BEVAR group and death, graft infection or thrombosis or para-anastomotic aneurysm in the open group.

    Measured: Through study completion, an average of 5 year

  4. Proximal aorta degeneration Proximal aorta degeneration

    Diameter increase >5 mm within 5 cm above the ostium of the more proximal target vessel for the endovascular group and 5 cm above the proximal anastomosis for the open group

    Measured: Through study completion, an average of 5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2022
  2. Study startJan 2010
  3. Primary completion31 Jan 2018
  4. Study completionJan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
278 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05247944
Sponsor's protocol ID
1843
Status last verified
Feb 2022
First submitted
31 Jan 2022
Last updated
21 Feb 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tinelli G, Crea MA, de Waure C, Di Tanna GL, Becquemin JP, Sobocinski J, Snider F, Haulon S. A propensity-matched comparison of fenestrated endovascular aneurysm repair and open surgical repair of pararenal and paravisceral aortic aneurysms. J Vasc Surg. 2018 Sep;68(3):659-668. doi: 10.1016/j.jvs.2017.12.060. Epub 2018 Mar 22.

    PubMed 29576405

Questions about this trial

What is this clinical trial studying?

An observational study of Aneurysm Aortic and Vascular Diseases, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall mortality (time frame: Through study completion, an average of 5 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05247944, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in